Element Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,587
Closed -$210K 855
2018
Q1
$210K Buy
+4,587
New +$210K ﹤0.01% 657